Altogether, these findings strongly suggest that LRRC3B has tumor suppressor qualities and is associated with slower tumor progression, better tumor staging, and reduced metastasis, and could serve as early biomarker for cancer detection, staging, and follow-up. The gene discussed is LRRC3B; the disease is neoplasm.